Zip Nucleic Acids: new high affinity oligonucleotides as potent primers for PCR and reverse transcription.
Most nucleic acid-based technologies rely upon sequence recognition between an oligonucleotide and its nucleic acid target. With the aim of improving hybridization by decreasing electrostatic repulsions between the negatively charged strands, novel modified oligonucleotides named Zip nucleic acids (ZNAs) were recently developed. ZNAs are oligonucleotide-oligocation conjugates whose global charge is modulated by the number of cationic spermine moieties grafted on the oligonucleotide. It was demonstrated that the melting temperature of a hybridized ZNA is easily predictable and increases linearly with the length of the oligocation. Furthermore, ZNAs retain the ability to discriminate between a perfect match and a single base-pair-mismatched complementary sequence. Using quantitative PCR, we show here that ZNAs are specific and efficient primers displaying an outstanding affinity toward their genomic target. ZNAs are particularly efficient at low magnesium concentration, low primer concentrations and high annealing temperatures, allowing to improve the amplification in AT-rich sequences and potentially multiplex PCR applications. In reverse transcription experiments, ZNA gene-specific primers improve the yield of cDNA synthesis, thus increasing the accuracy of detection, especially for genes expressed at low levels. Our data suggest that ZNAs exhibit faster binding kinetics than standard and locked nucleic acid-containing primers, which could explain why their target recognition is better for rare targets.
Moreau
Valérie
V
Polyplus-transfection SA, Bioparc, Illkirch, France.
Voirin
Emilie
E
Paris
Clément
C
Kotera
Mitsuharu
M
Nothisen
Marc
M
Rémy
Jean-Serge
JS
Behr
Jean-Paul
JP
Erbacher
Patrick
P
Lenne-Samuel
Nathalie
N
D020856:AT Rich Sequence; D017931:DNA Primers; D016133:Polymerase Chain Reaction / Q000592:standards; D048348:Reverse Transcription
D017931:DNA Primers
Biotechnol Bioeng. 2005 Nov 5;92(3):346-55
16170827
Clin Chem. 2004 Mar;50(3):509-15
14726469
Biochemistry. 2008 May 13;47(19):5336-53
18422348
J Am Chem Soc. 2008 Oct 8;130(40):13500-5
18781743
J Clin Microbiol. 2005 Sep;43(9):4868-71
16145162
Proc Natl Acad Sci U S A. 1995 Apr 25;92(9):3814-8
7731989
Mol Cell Probes. 2003 Oct;17(5):253-9
14580400
Chembiochem. 2006 Aug;7(8):1173-6
16874748
Anal Biochem. 1997 Feb 15;245(2):154-60
9056205
Genes Dev. 2007 May 1;21(9):1025-30
17437991
J Biol Chem. 1995 Jun 16;270(24):14712-7
7782335
Clin Chem. 2002 Aug;48(8):1329-37
12142391
Mol Aspects Med. 2006 Apr-Jun;27(2-3):95-125
16460794
Biochemistry. 2004 May 11;43(18):5388-405
15122905
Nucleic Acids Res. 2005 Nov 27;33(21):e182
16314296
Clin Chem. 2009 Apr;55(4):611-22
19246619
Biochim Biophys Acta. 2000 Nov 15;1494(1-2):23-7
11072065
Clin Biochem. 2004 Oct;37(10):930-2
15369726
Nucleic Acids Res. 2000 Jan 15;28(2):655-61
10606668
BMC Mol Biol. 2007 Oct 22;8:93
17953766
Nat Protoc. 2006;1(3):1559-82
17406449
Nucleic Acids Res. 1997 Jul 1;25(13):2657-60
9185578
Nucleic Acids Symp Ser (Oxf). 2008;(52):417-8
18776431
J Mol Endocrinol. 2005 Jun;34(3):597-601
15956331
Mol Biotechnol. 2004 Feb;26(2):133-46
14764939
Nucleic Acids Res. 2006;34(20):e142
17071964
BMC Res Notes. 2008 Aug 28;1:70
18755023
Biotechniques. 2002 Apr;32(4):768, 770, 772, 754-5
11962598
Biochem J. 2001 Mar 15;354(Pt 3):481-4
11237851
J Gen Virol. 1995 Apr;76 ( Pt 4):1057-62
9049358
J Clin Microbiol. 2001 Feb;39(2):485-93
11158094
Nat Protoc. 2007;2(6):1360-7
17545974
Biochemistry. 1991 Apr 30;30(17):4357-61
2021627
J Biomol Tech. 2004 Sep;15(3):155-66
15331581
Int J Mol Med. 2004 Apr;13(4):521-5
15010851